TEMAZEPAM

Temazepam Adverse Events Reported to the FDA Over Time

How are Temazepam adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Temazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Temazepam is flagged as the suspect drug causing the adverse event.

Most Common Temazepam Adverse Events Reported to the FDA

What are the most common Temazepam adverse events reported to the FDA?

Completed Suicide	314 (4.87%)
Death	244 (3.79%)
Drug Toxicity	170 (2.64%)
Cardiac Arrest	110 (1.71%)
Overdose	106 (1.64%)
Loss Of Consciousness	94 (1.46%)
Respiratory Arrest	89 (1.38%)
Somnolence	88 (1.37%)
Drug Interaction	85 (1.32%)
Multiple Drug Overdose	79 (1.23%)
Confusional State	78 (1.21%)
	Show More
Anxiety	75 (1.16%)
Amnesia	72 (1.12%)
Suicide Attempt	71 (1.1%)
Hypotension	69 (1.07%)
Cardio-respiratory Arrest	62 (.96%)
Poisoning	61 (.95%)
Drug Ineffective	58 (.9%)
Metabolic Acidosis	58 (.9%)
Hypoxia	56 (.87%)
Multiple Drug Overdose Intentional	51 (.79%)
Vomiting	50 (.78%)
Drug Abuse	48 (.74%)
Intentional Overdose	48 (.74%)
Headache	45 (.7%)
Malaise	45 (.7%)
Unresponsive To Stimuli	45 (.7%)
Insomnia	44 (.68%)
Fall	42 (.65%)
Depression	40 (.62%)
Dizziness	40 (.62%)
Heart Rate Increased	40 (.62%)
Musculoskeletal Stiffness	40 (.62%)
Accidental Overdose	38 (.59%)
Mesothelioma	38 (.59%)
Tachycardia	38 (.59%)
Dysarthria	37 (.57%)
Agitation	32 (.5%)
Lung Neoplasm Malignant	32 (.5%)
Dyspnoea	31 (.48%)
Abdominal Pain	29 (.45%)
Fatigue	29 (.45%)
Pulmonary Congestion	29 (.45%)
Suicidal Ideation	29 (.45%)
Therapeutic Agent Toxicity	29 (.45%)
Pulmonary Oedema	28 (.43%)
Chills	27 (.42%)
Pruritus	27 (.42%)
Respiratory Depression	27 (.42%)
Memory Impairment	26 (.4%)
Pneumonia	26 (.4%)
Blood Pressure Decreased	25 (.39%)
Depressed Level Of Consciousness	25 (.39%)
Diarrhoea	25 (.39%)
Medication Error	25 (.39%)
Weight Decreased	25 (.39%)
Abnormal Dreams	24 (.37%)
Back Pain	24 (.37%)
Crystalluria	24 (.37%)
Drug Withdrawal Syndrome	24 (.37%)
Hallucination	24 (.37%)
Nervousness	24 (.37%)
Jaundice	23 (.36%)
Imprisonment	22 (.34%)
Palpitations	22 (.34%)
Pancreatic Carcinoma	22 (.34%)
Photophobia	22 (.34%)
Vision Blurred	22 (.34%)
Cerebrovascular Accident	21 (.33%)
Drug Dependence	21 (.33%)
Dry Mouth	21 (.33%)
Duodenal Ulcer	21 (.33%)
Gastritis	21 (.33%)
Pneumonia Aspiration	21 (.33%)
Blood Creatine Phosphokinase Increa...	20 (.31%)
Coma	20 (.31%)
Intentional Drug Misuse	20 (.31%)
Pyrexia	20 (.31%)
Sexual Abuse	20 (.31%)
Gastrointestinal Disorder	19 (.29%)
Hypertension	19 (.29%)
Mood Altered	19 (.29%)
Reflux Oesophagitis	19 (.29%)
Feeling Abnormal	18 (.28%)
Mental Status Changes	18 (.28%)
Alanine Aminotransferase Increased	17 (.26%)
Electrocardiogram Qt Prolonged	17 (.26%)
Hepatic Encephalopathy	17 (.26%)
Hypersensitivity	17 (.26%)
Lower Respiratory Tract Infection	17 (.26%)
Sedation	17 (.26%)
Accidental Death	16 (.25%)
Asthma	16 (.25%)
Drug Effect Decreased	16 (.25%)
Drug Level Increased	16 (.25%)
Multiple Drug Overdose Accidental	16 (.25%)
Nausea	16 (.25%)
Oesophageal Haemorrhage	16 (.25%)
Oxygen Saturation Decreased	16 (.25%)
Snoring	16 (.25%)
Abnormal Behaviour	15 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Temazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Temazepam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Temazepam

What are the most common Temazepam adverse events reported to the FDA?

Neurological	466 (7.23%)
Suicidal And Self-injurious Behavio...	432 (6.7%)
Medication Errors	404 (6.27%)
Respiratory	303 (4.7%)
Chemical Injury And Poisoning	294 (4.56%)
Fatal Outcomes	271 (4.2%)
Cardiac Arrhythmias	269 (4.17%)
Therapeutic And Nontherapeutic Effe...	202 (3.13%)
Anxiety Disorders	161 (2.5%)
Psychiatric	144 (2.23%)
Injuries	140 (2.17%)
	Show More
Cardiac And Vascular Investigations	126 (1.96%)
Gastrointestinal Signs	116 (1.8%)
Mental Impairment	109 (1.69%)
Sleep Disorders	108 (1.68%)
Lower Respiratory Tract Disorders	97 (1.51%)
Deliria	96 (1.49%)
Musculoskeletal And Connective Tiss...	81 (1.26%)
Decreased And Nonspecific Blood Pre...	78 (1.21%)
Metabolic, Nutritional And Blood Ga...	76 (1.18%)
Epidermal And Dermal Conditions	74 (1.15%)
Infections - Pathogen Unspecified	69 (1.07%)
Hepatic And Hepatobiliary	66 (1.02%)
Physical Examination Topics	63 (.98%)
Acid-base	62 (.96%)
Disturbances In Thinking	52 (.81%)
Gastrointestinal Inflammatory Condi...	48 (.74%)
Headaches	48 (.74%)
Toxicology And Therapeutic Drug Mon...	46 (.71%)
Legal Issues	45 (.7%)
Depressed Mood Disorders	44 (.68%)
Lifestyle Issues	41 (.64%)
Mesotheliomas	41 (.64%)
Hepatobiliary	40 (.62%)
Urinary Tract Signs	40 (.62%)
Mood Disorders	39 (.61%)
Water, Electrolyte And Mineral	39 (.61%)
Gastrointestinal Ulceration And Per...	38 (.59%)
Vision	38 (.59%)
Central Nervous System Vascular	37 (.57%)
Gastrointestinal Motility And Defec...	36 (.56%)
Respiratory And Mediastinal Neoplas...	35 (.54%)
Renal And Urinary Tract Investigati...	31 (.48%)
Renal Disorders	31 (.48%)
Seizures	31 (.48%)
Cardiac Disorder Signs	29 (.45%)
Coronary Artery	29 (.45%)
Enzyme	29 (.45%)
Bronchial Disorders	28 (.43%)
Myocardial	28 (.43%)
Ocular Neuromuscular	28 (.43%)
Hematology Investigations	26 (.4%)
Personality Disorders	26 (.4%)
Allergic Conditions	25 (.39%)
Body Temperature Conditions	25 (.39%)
Changes In Physical Activity	25 (.39%)
Gastrointestinal Hemorrhages	25 (.39%)
Muscle	25 (.39%)
Glucose Metabolism Disorders	24 (.37%)
Neuromuscular	24 (.37%)
Arteriosclerosis, Stenosis, Vascula...	23 (.36%)
Gastrointestinal Conditions	23 (.36%)
Vascular Hypertensive	23 (.36%)
Electrolyte And Fluid Balance Condi...	22 (.34%)
Gastrointestinal Neoplasms Malignan...	22 (.34%)
Movement Disorders	22 (.34%)
Ocular Sensory Symptoms	22 (.34%)
Salivary Gland Conditions	22 (.34%)
Psychiatric And Behavioural Symptom...	21 (.33%)
Vascular	21 (.33%)
Product Quality Issues	19 (.29%)
Encephalopathies	18 (.28%)
Appetite And General Nutritional	17 (.26%)
Sexual Function And Fertility	17 (.26%)
Skin Appendage Conditions	16 (.25%)
Hematological And Lymphoid Tissue T...	15 (.23%)
Pulmonary Vascular	13 (.2%)
Increased Intracranial Pressure And...	12 (.19%)
Schizophrenia And Other Psychotic	12 (.19%)
Bone And Joint Injuries	11 (.17%)
Therapeutic Procedures And Supporti...	11 (.17%)
Joint	10 (.16%)
Peritoneal And Retroperitoneal Cond...	10 (.16%)
Upper Respiratory Tract Disorders	10 (.16%)
Bacterial Infectious	9 (.14%)
Eye	9 (.14%)
Tissue	9 (.14%)
Cranial Nerve Disorders	8 (.12%)
White Blood Cell	8 (.12%)
Gastrointestinal Therapeutic Proced...	7 (.11%)
Inner Ear And Viiith Cranial Nerve	7 (.11%)
Nephropathies	7 (.11%)
Procedural And Device Related Injur...	7 (.11%)
Vascular Hemorrhagic	7 (.11%)
Adrenal Gland	6 (.09%)
Bone And Joint Therapeutic Procedur...	6 (.09%)
Gastrointestinal Stenosis And Obstr...	6 (.09%)
Sleep Disturbances	6 (.09%)
Heart Failures	5 (.08%)
Impulse Control	5 (.08%)
Ocular Infections, Irritations And ...	5 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Temazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Temazepam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.